AGREEMENT CONTAINING CONSENT ORDERSJuly 20th, 2017
FiledJuly 20th, 2017The Federal Trade Commission (“Commission”), having initiated an investigation of the proposed acquisition by Baxter International Inc. of the voting securities of certain entities (defined in the attached proposed Decision and Order as “Claris Generic Pharmaceutical Entities”) and related assets from Claris Lifesciences Limited (“Claris”) and their ultimate parent entity Mr. Arjun Handa (Baxter, Claris, and Mr. Handa, hereinafter collectively referred to as “Proposed Respondents”), and it now appearing that Proposed Respondents are willing to enter into this Agreement Containing Consent Orders (“Consent Agreement”) to divest certain assets and providing for other relief: